Bumetanide Equivalent Dose for Furosemide 120 mg Twice Daily
For furosemide (Lasix) 120 mg twice daily (240 mg total daily dose), the equivalent bumetanide dose is 6 mg daily, typically given as 3 mg twice daily.
Dose Conversion Rationale
The standard conversion ratio between furosemide and bumetanide is 40:1 1, 2, 1. This ratio is consistently supported across multiple guidelines and research studies:
- Guideline consensus: The 2008 ESC Heart Failure Guidelines explicitly state that 20-40 mg furosemide IV equals 0.5-1 mg bumetanide 1
- Research validation: A 2013 retrospective study in heart failure patients confirmed a potency ratio of 41:1 for intermittent IV dosing and 34:1 overall, supporting the standard 40:1 conversion 3
- Clinical practice: The 2013 ACC/AHA Heart Failure Guidelines list bumetanide starting doses of 0.5-1 mg corresponding to furosemide 20-40 mg 2
Calculation
- Furosemide 240 mg daily ÷ 40 = 6 mg bumetanide daily
- Typical dosing: 3 mg twice daily (or 6 mg once daily, though twice daily is more common)
Important Clinical Considerations
Bioavailability Differences
Bumetanide has superior oral bioavailability (80-90%) compared to furosemide (10-90%, average ~50%) 4. This means:
- Oral-to-IV conversion for bumetanide is approximately 1:1 4
- Oral-to-IV conversion for furosemide is approximately 2:1 4
- When switching from oral furosemide to oral bumetanide, the 40:1 ratio remains appropriate
Monitoring Requirements
When converting between loop diuretics, monitor closely:
- Daily weights and urine output in first 48-72 hours
- Electrolytes and renal function within 5-7 days 5
- Volume status (orthopnea, edema, jugular venous pressure)
- Target weight loss: 0.5-1 kg/day without peripheral edema, up to 1 kg/day with edema 4
Dose Titration
- Maximum bumetanide dose: 10 mg/day orally 2, 6
- If inadequate response at 6 mg daily, increase by 1-2 mg increments 6
- Consider adding thiazide (metolazone 2.5-5 mg) for diuretic resistance rather than exceeding maximum doses 1, 2
Potential Advantages of Bumetanide
- More predictable absorption due to higher bioavailability 7, 8
- Lower risk of ototoxicity compared to furosemide 7, 8
- Easier dose titration in patients with gastrointestinal edema affecting absorption 8
Common Pitfalls to Avoid
- Don't underdose: Using ratios less than 40:1 may result in inadequate diuresis
- Don't forget potassium monitoring: Both drugs cause similar potassium wasting despite bumetanide being more potent 7
- Reassess need regularly: The goal is the lowest effective dose to maintain euvolemia 2
- Watch for contraction alkalosis: May require acetazolamide addition in refractory cases 4